SENS Key Statistics, Chart & Performance
The current stock price of SENS is 6.96 USD. In the past month the price increased by 26.32%. In the past year, price decreased by -63.78%.
SENS Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to SENS. When comparing the yearly performance of all stocks, SENS is a bad performer in the overall market: 89.99% of all stocks are doing better.
SENS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SENS. The financial health of SENS is average, but there are quite some concerns on its profitability.
SENS Financial Highlights
Over the last trailing twelve months SENS reported a non-GAAP Earnings per Share(EPS) of -1.63. The EPS increased by 37.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.57% | ||
| ROE | -81.58% | ||
| Debt/Equity | 0.45 |
SENS Forecast & Estimates
14 analysts have analysed SENS and the average price target is 19.3 USD. This implies a price increase of 177.23% is expected in the next year compared to the current price of 6.96.
For the next year, analysts expect an EPS growth of 30.95% and a revenue growth 59.44% for SENS
SENS Ownership
About SENS
Company Profile
Senseonics Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Germantown, Maryland and currently employs 117 full-time employees. The company went IPO on 2015-03-04. Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
Company Info
SENSEONICS HOLDINGS INC
20451 Seneca Meadows Pkwy
Germantown MARYLAND 20876 US
CEO: Timothy T. Goodnow
Employees: 117
Phone: 13015157260
SENSEONICS HOLDINGS INC / SENS FAQ
Can you describe the business of SENSEONICS HOLDINGS INC?
Senseonics Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Germantown, Maryland and currently employs 117 full-time employees. The company went IPO on 2015-03-04. Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
Can you provide the latest stock price for SENSEONICS HOLDINGS INC?
The current stock price of SENS is 6.96 USD. The price increased by 2.05% in the last trading session.
Does SENS stock pay dividends?
SENS does not pay a dividend.
What is the ChartMill technical and fundamental rating of SENS stock?
SENS has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the market expecting SENS stock to perform?
14 analysts have analysed SENS and the average price target is 19.3 USD. This implies a price increase of 177.23% is expected in the next year compared to the current price of 6.96.
What is the Price/Earnings (PE) ratio of SENSEONICS HOLDINGS INC (SENS)?
SENSEONICS HOLDINGS INC (SENS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.63).
When does SENSEONICS HOLDINGS INC (SENS) report earnings?
SENSEONICS HOLDINGS INC (SENS) will report earnings on 2026-05-06.